|
CAS-Nr. | 877399-52-5 |
Bezeichnung: | |
Englisch Name: | 3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-2-Pyridinamine |
Synonyma: | Xalkori;PF 2341066;Crizotinib;Crozotinib;PF-02341066;PF-2341066/Crizotinib;Crizotinib,PF-02341066;Crizotinib (PF2341066);PF-02341066 Crizotinib;k-ras(g12c) inhibitor 6 NA
Crizotinib |
CBNumber: | CB12473904 |
Summenformel: | C21H22Cl2FN5O |
Molgewicht: | 450.343 |
MOL-Datei: | 877399-52-5.mol |
|
|
|
|
3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-2-Pyridinamine physikalisch-chemischer Eigenschaften |
|
3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-2-Pyridinamine Chemische Eigenschaften,Einsatz,Produktion Methoden |
Chemische Eigenschaften White Solid |
|
Verwenden A potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK). A potential antitumor agent. |
|
Verwenden Crizotinib is a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK). Crizotinib is a potential antitumor agent. |
|
Verwenden PF-2341066 (Crizotinib) is a potent inhibitor of c-Met and ALK with IC50 of 11 nM and 24 nM, respectivley |
|
|
3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-2-Pyridinamine Upstream-Materialien And Downstream Produkte |
Upstream-Materialien
|
Downstream Produkte
|
3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-2-Pyridinamine Anbieter Lieferant Produzent Hersteller Vertrieb Händler. Global( 151)Lieferanten |
|
|
|
|
877399-52-5(3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-2-Pyridinamine)Verwandte Suche: |
|
3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-2-Pyridinamine
877399-52-5
C21H22Cl2FN5O
(R)-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-amine
3-[(1R)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]pyridin-2-amine
Crizotinib
PF 2341066
PF-02341066
PF-2341066/Crizotinib
3-[1-(2,6-Dichloro-3-fluoro-phenyl)-ethoxy]-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)-pyridin-2-ylamine
Aromatic
Chiral Reagents
Heterocycles
Inhibitors
Intermediates & Fine Chemicals
Pfizer Compounds
Pharmaceuticals
3-[(1R)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)-1H-pyrazol-4-yl]-2-aMinopyridine
Crizotinib,PF-02341066
Xalkori
(R)-3-[1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-yl-1H- pyrazol-4-yl)pyridin-2-ylaMine
[3-[[(R)-1-(2,6-Dichloro-3-
fluorophenyl)ethyl]oxy]-5-[1-(piperidin-4-yl)-1H-pyrazol-4-yl]pyridin-2-yl]aMine
2-PyridinaMine, 3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-
Crozotinib
Inhibitor
Crizotinib (PF2341066)
PF-02341066 Crizotinib
Anti-cancer & immunity
3-((R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-amine
k-ras(g12c) inhibitor 6 NA
Crizotinib
|
Urheberrecht 2009 © ChemicalBook. Alle Rechte vorbehalten. |